Metals Joint Ventures Investment Data Centers Commodity Prices Clean Energy Sector Synthetic Biology Battery Technology Electric Powertrains Executive Orders
The technique leverages a biocompatible Lossen rearrangement in engineered bacteria to turn PET-derived compounds into pharmaceutical precursors pending commercial scale-up